Cannidex Brands Signs License Agreement With Alternative Solutions To Distribute CANNIDEX+ In Washington, DC

Monday, May 21, 2018 Medico Legal News
Email Print This Page Comment bookmark
Font : A-A+

WASHINGTON, May 21, 2018 /PRNewswire/ -- Cannidex Brands, a leading topical cannabis provider, continues its licensing expansion

by signing an exclusive license agreement with Alternative Solutions, Washington, DC's premier cannabis cultivator.  The agreement allows Alternative Solutions to manufacture CANNIDEX+ and distribute the product to all
licensed Washington, DC dispensaries.  

"We couldn't be more excited to be working with the exceptional team at Alternative Solutions," said Scott Gerhardt with Cannidex Brands.  "We had the incredible opportunity to come to Washington and tour several dispensaries, and are pleased to be collaborating with Alternative Solutions to bring CANNIDEX+ to this wonderful and thriving community."  

"Alternative Solutions is very excited to be partnering with Cannidex Brands and introducing their exclusive topical cream to the Washington DC dispensaries," said Matt Lawson-Baker, Chief Operating Officer of Alternative Solutions.  "With the recent regulatory changes to include reciprocity with other medical marijuana states, we will be able to serve patients from around the nation with this new product."  

About Cannidex BrandsCannidex Brands is the premier provider of high quality, high potency topical cannabis products. CANNIDEX+ is a full spectrum cannabis topical currently available in select US markets with statewide medical or recreational cannabis programs. For more information, please visit www.cannidex.com.  

Cision View original content:http://www.prnewswire.com/news-releases/cannidex-brands-signs-license-agreement-with-alternative-solutions-to-distribute-cannidex-in-washington-dc-300651508.html

SOURCE Cannidex Brands

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store